Raffles Medical Group Limited operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Raffles Medical Group Limited with three other
health care providers in Asia:
Siloam International Hospitals Tbk Pt
sales of 5.85 trillion Indonesian Rupiahs [US$414.62 million]
of which 34%
Yihua Healthcare Co Ltd
(2.12 billion Chinese Renmimbi [US$312.73 million]
of which 92%
was medical business), and
Samitivej Public Company Limited
based in Thailand
(10.78 billion Thai Bahts [US$345.35 million]
of which 100%
Raffles Medical Group Limited reported sales of 477.58 million Singapore Dollars (US$351.94 million)
December of 2017.
a very small
increase of 0.8%
versus 2016, when the company's sales were 473.61 million Singapore Dollars.
Sales at Raffles Medical Group Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 53%).
Sales of Investment Holdings saw an increase
that was more than double the company's growth rate: sales were up
21.1% in 2017, from
17.69 million Singapore Dollars to 21.42 million Singapore Dollars.
Raffles Medical Group Limited also saw significant increases in sales in
Hospital Services (up 2.3% to 291.81 million Singapore Dollars)
Not all segments of Raffles Medical Group Limited experienced an increase in sales in 2017:
sales of Healthcare fell 1.6% to 206.57 million Singapore Dollars.